|
NEO1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.941250E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.965800E-04 |
| Normal-vs-Stage2 |
1.247220E-04 |
| Normal-vs-Stage3 |
1.869780E-01 |
| Normal-vs-Stage4 |
3.324400E-01 |
| Stage1-vs-Stage2 |
1.879020E-01 |
| Stage1-vs-Stage3 |
2.551400E-01 |
| Stage1-vs-Stage4 |
7.158400E-01 |
| Stage2-vs-Stage3 |
6.277700E-02 |
| Stage2-vs-Stage4 |
4.553600E-01 |
| Stage3-vs-Stage4 |
7.676400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.625000E-03 |
| Normal-vs-AfricanAmerican |
9.060100E-03 |
| Normal-vs-Asian |
4.644000E-02 |
| Caucasian-vs-AfricanAmerican |
6.633800E-01 |
| Caucasian-vs-Asian |
6.110800E-01 |
| AfricanAmerican-vs-Asian |
6.915400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.216570E-03 |
| Normal-vs-Female |
4.638200E-01 |
| Male-vs-Female |
6.743800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.566270E-02 |
| Normal-vs-Extreme_Weight |
4.213600E-04 |
| Normal-vs-Obese |
8.160200E-02 |
| Normal-vs-Extreme_Obese |
1.348050E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.102800E-01 |
| Normal_Weight-vs-Obese |
3.245200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.026000E-01 |
| Extreme_Weight-vs-Obese |
7.378200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.024200E-01 |
| Obese-vs-Extreme_Obese |
2.918000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.378400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.778410E-01 |
| Normal-vs-Age(61-80Yrs) |
2.359200E-04 |
| Normal-vs-Age(81-100Yrs) |
3.629600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.705190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.473600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.597800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.021430E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.151400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.039400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.579500E-03 |
| Normal-VS-Type2 PRCC |
4.822500E-03 |
| Normal-VS-KIRP CIMP |
3.310000E-01 |
| Normal-VS-Unclassified PRCC |
2.547600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.978400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.979400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.854000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.318000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.827800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.978600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.009400E-04 |
| Normal-vs-N1 |
5.764200E-01 |
| Normal-vs-N2 |
8.380600E-01 |
| N0-vs-N1 |
6.307900E-02 |
| N0-vs-N2 |
4.132200E-01 |
| N1-vs-N2 |
6.080400E-01 |
|
|
